Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Allison O'neill, Md

Clinical trials sponsored by Allison O'neill, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Keytruda takes on childhood liver cancer: new hope for relapsed patients? Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Keytruda takes on childhood liver cancer: new hope for relapsed patients?

Disease control Recruiting now

This phase 2 trial is testing the immunotherapy drug pembrolizumab (Keytruda) in children and young adults up to age 30 with relapsed or hard-to-treat liver cancer. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Researchers will also study how the i…

Phase 2 • Sponsor: Allison O'Neill, MD • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC